Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The human pregnancy-specific glycoproteins (PSGs) are a family of proteins that are synthesized in large amounts by placental trophoblasts and released into the maternal circulation during pregnancy. Additionally we are shipping CEA Antibodies (628) and CEA Kits (71) and many more products for this protein.
Showing 10 out of 46 products:
Human CEA Protein expressed in Human - ABIN2128486
Martínez-Mancera, García-López, Hernández-López: Pre-clinical validation study of a miniaturized electrochemical immunoassay based on square wave voltammetry for early detection of carcinoembryonic antigen in human serum. in Clinica chimica acta; international journal of clinical chemistry 2015
Show all 2 Pubmed References
Human CEA Protein expressed in Human - ABIN935259
Lima, Jenkins, Guerrero, Triozzi, Shaw, Strong: A DNA vaccine encoding genetic fusions of carcinoembryonic antigen (CEA) and granulocyte/macrophage colony-stimulating factor (GM-CSF). in Vaccine 2005
In a cohort with non-small cell lung cancer, serum CEA levels were abnormally high in 54.3% of the patients. Increasing serum CEA was correlated with tumor EGFR (show EGFR Proteins) mutation.
Data indicate that serum carcino-embryonic antigen (CEA) has a tendency to increase over time in patients with urinary diversion (UD) but is not a valuable marker of secondary neoplasms in these patients.
Findings suggested the possible role of carcinoembryonic antigen (CEA (show CEACAM5 Proteins)) in the pathogenesis of brain invasion.
CEA mRNA, CK20 (show KRT20 Proteins) mRNA, and serum CEA than patients at stages I-III.
CEA acts to promote the metastatic dissemination of tumor cells. On depletion of CEA, the metastatic potential of LS174T cells is dramatically reduced.
The significant expression of IMP3 (show SPPL2A Proteins) and CEA in less well-differentiated foci of mucinous MDA may be helpful in the diagnosis of mucinous MDA to some extent.
Vaccination with the plasmid for the triple repeated CEA peptides induced stronger Th1 (show HAND1 Proteins) responses
Elevated levels of CEA are associated with pancreatic cancer and new-onset diabetes.
Data show that Ad5 (show PSEN2 Proteins) immune mice bearing CEA-expressing tumors that were treated with Ad5 (show PSEN2 Proteins) [E1-, E2b (show DBT Proteins)-]-CEA had increased anti-tumor response as compared with Ad5 (show PSEN2 Proteins) [E1-]-CEA treated mice.
Study shows that it is possible to use ultrasound to amplify and localize the source of CEA levels in blood of tumor-bearing mice and will allow for a previously undescribed way to determine the presence and localization of disease more accurately.
Integrating the dual-signal amplification strategy, a novel 3D origami electrochemical immunodevice for simultaneous detecting carcinoembryonic antigen (CEA (show CEACAM5 Proteins)) and cancer antigen 125 (CA125 (show MUC16 Proteins))
the authors evaluated the prognostic significance of the CEA (show CEACAM5 Proteins) and CA-19.9 serum tumor markers in advanced (unresectable) pancreatic cancer
This genetic cancer vaccineis highly immunogenic and can break tolerance to CEA (show CEACAM5 Proteins) tumor antigen in CEA (show CEACAM5 Proteins) transgenic mice.
The human pregnancy-specific glycoproteins (PSGs) are a family of proteins that are synthesized in large amounts by placental trophoblasts and released into the maternal circulation during pregnancy. Molecular cloning and analysis of several PSG genes has indicated that the PSGs form a subgroup of the carcinoembryonic antigen (CEA) gene family, which belongs to the immunoglobulin superfamily of genes. Members of the CEA family consist of a single N domain, with structural similarity to the immunoglobulin variable domains, followed by a variable number of immunoglobulin constant-like A and/or B domains. Most PSGs have an arg-gly-asp (RGD) motif, which has been shown to function as an adhesion recognition signal for several integrins, in the N-terminal domain (summary by Teglund et al., 1994
, carcinoembryonic antigen SG8
, pregnancy-specific beta-1 glycoprotein E
, pregnancy-specific beta-1-glycoprotein 2
, pregnancy-specific beta-1-glycoprotein 7
, pregnancy-specific beta-1-glycoprotein-2
, pregnancy-specific glycoprotein 2